Peyrin-Biroulet L - Search Results

1

An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.

Attar A, Branche J, Coron E, Privat J, Caillo L, Chevaux JB, Vuitton L, Amiot A, Belkhodja H, Dray X, Ponchon T, Bouhnik Y, Baumann C, Peyrin-Biroulet L. Attar A, et al. J Crohns Colitis. 2021 Apr 6;15(4):521-528. doi: 10.1093/ecco-jcc/jjaa208. J Crohns Colitis. 2021. PMID: 33106876

2

IBD serological panels: facts and perspectives.

Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. Peyrin-Biroulet L, et al. Inflamm Bowel Dis. 2007 Dec;13(12):1561-6. doi: 10.1002/ibd.20226. Inflamm Bowel Dis. 2007. PMID: 17636565 Review.

3

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53. doi: 10.1016/j.cgh.2008.03.014. Clin Gastroenterol Hepatol. 2008. PMID: 18550004

4

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group. Beaugerie L, et al. Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7. Lancet. 2009. PMID: 19837455

5

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L. Chevaux JB, et al. Inflamm Bowel Dis. 2010 Jun;16(6):916-24. doi: 10.1002/ibd.21147. Inflamm Bowel Dis. 2010. PMID: 19885908

6

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.

Oussalah A, Chevaux JB, Fay R, Sandborn WJ, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Am J Gastroenterol. 2010 May;105(5):1142-9. doi: 10.1038/ajg.2010.158. Epub 2010 Apr 13. Am J Gastroenterol. 2010. PMID: 20389296

7

Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Chevaux JB, Peyrin-Biroulet L. Chevaux JB, et al. Gastroenterol Hepatol (N Y). 2010 Feb;6(2):122-4. Gastroenterol Hepatol (N Y). 2010. PMID: 20567556 Free PMC article. No abstract available.

8

Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab.

Pillot C, Chevaux JB, Petitpain N, Peyrin-Biroulet L. Pillot C, et al. Inflamm Bowel Dis. 2011 Feb;17(2):679. doi: 10.1002/ibd.21321. Inflamm Bowel Dis. 2011. PMID: 20848494 No abstract available.

9

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Chevaux JB, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Inflamm Bowel Dis. 2011. PMID: 20949566 Review.

10

Infliximab 10 mg/kg every 3 weeks for Crohn's disease.

Pillot C, Chevaux JB, Bigard MA, Peyrin-Biroulet L. Pillot C, et al. Am J Gastroenterol. 2010 Nov;105(11):2509-10. doi: 10.1038/ajg.2010.244. Am J Gastroenterol. 2010. PMID: 21048692 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,101 results

Search Page

Filters